These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11377499)

  • 1. The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection.
    McGrath JS; Shehata M
    Transplant Proc; 2001 May; 33(3):2191-2. PubMed ID: 11377499
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of RS61443 on chronic rejection of rat kidney allografts.
    Azuma H; Binder J; Heemann U; Tullius SG; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):436-7. PubMed ID: 7879052
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
    Schuurman HJ; Beckmann N; Briner U; Bruns C; Bruttel K; Tanner M; Tolcsvai L; Weckbecker G
    Transplant Proc; 1996 Dec; 28(6):3272-5. PubMed ID: 8962271
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of renal mass on chronic kidney allograft rejection in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie HS; Schmid C; Brenner BM; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of tolerance in a chronic rejection model.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Rayes N; Qun Y; Volk HD; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1075-6. PubMed ID: 9636436
    [No Abstract]   [Full Text] [Related]  

  • 6. Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
    Fritsche L; Sperschneider H; Budde K; Giessing M; Türk H; Böhler T; Schröder K; Stein G; Neumayer HH
    Transplant Proc; 1998 Aug; 30(5):2229. PubMed ID: 9723451
    [No Abstract]   [Full Text] [Related]  

  • 7. Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era.
    Morozumi K; Oikawa T; Fukuda M; Sugito K; Takeuchi O; Usami T; Fujinami T; Yokoyama I; Takagi H; Takeda A; Koyama K; Yoshida A; Haba T; Tominaga Y; Uchida K
    Transplant Proc; 1997; 29(1-2):89-92. PubMed ID: 9123167
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of hepatocyte growth factor on chronic rejection in rat renal allografts.
    Azuma H; Takahara S; Kitamura M; Wang JD; Wega A; Sayegh MH; Suzuki S; Matsumoto K; Nakamura T; Okuyama A; Katsuoka Y
    Transplant Proc; 1999; 31(1-2):854-5. PubMed ID: 10083372
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAD reduces compensatory renal graft hypertrophy in a rat model of chronic rejection.
    Viklický O; Müller V; Zou H; Szabó A; Vitko S; Heemann U
    Transplant Proc; 2001 May; 33(3):2320-1. PubMed ID: 11377546
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejection.
    Tullius SG; Nieminen M; Qun Y; Egermann F; Reutzer-Selke A; Jonas S; Pratschke J; Bechstein WO; Volk HD; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2411-2. PubMed ID: 9723521
    [No Abstract]   [Full Text] [Related]  

  • 12. Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
    Washburn WK; Shaffer D; Simpson MA; Conway P; Madras PN; Monaco AP
    Transplant Proc; 1996 Apr; 28(2):1015-6. PubMed ID: 8623214
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients.
    Kliem V; Boeck A; Eisenberger U; Petersen R; Radermacher J; Hiss M; Pethig M; Koch KM; Nashan B; Brunkhorst R
    Transplant Proc; 1999; 31(1-2):1312-3. PubMed ID: 10083586
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of IL-10 by FK 506 may be responsible for overcoming ongoing allograft rejection in the rat.
    Jiang H; Yang XF; Soriano R; Fujitsu T; Kobayashi M
    Transplant Proc; 1999; 31(1-2):1203-5. PubMed ID: 10083538
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
    Noris M; Azzollini N; Pezzotta A; Mister M; Benigni A; Marchetti G; Gagliardini E; Perico N; Remuzzi G
    J Am Soc Nephrol; 2001 Sep; 12(9):1937-1946. PubMed ID: 11518788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 18. A second native renal allograft of donor origin in a model of chronic rejection demonstrates improved long-term function.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Steinmüller T; Pratschke J; Zeilinger K; Graser E; Volk HD; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):3029. PubMed ID: 9365655
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.
    Cole O; Rigg K; Shehata M
    Ann R Coll Surg Engl; 2001 Jul; 83(4):235-43. PubMed ID: 11518369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.